Acadia Pharmaceuticals
ACAD
ACAD
183 hedge funds and large institutions have $2.49B invested in Acadia Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 56 increasing their positions, 55 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5% less first-time investments, than exits
New positions opened: 37 | Existing positions closed: 39
2% less funds holding
Funds holding: 186 → 183 (-3)
Holders
183
Holding in Top 10
2
Calls
$65.2M
Puts
$47.3M
Top Buyers
| 1 | +$67.8M | |
| 2 | +$55.4M | |
| 3 | +$49.6M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$25.1M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$24.4M |
Top Sellers
| 1 | -$65.4M | |
| 2 | -$26.7M | |
| 3 | -$16.7M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
-$16.1M |
| 5 |
O
OppenheimerFunds
New York
|
-$15.5M |